{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T23:38:20Z","timestamp":1793403500803,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T00:00:00Z","timestamp":1675036800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T00:00:00Z","timestamp":1675036800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Tianjin Science and Technology Committee Foundation","award":["21JCYBJC01820"],"award-info":[{"award-number":["21JCYBJC01820"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-023-00998-2","type":"journal-article","created":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T05:04:44Z","timestamp":1675055084000},"page":"2209-2220","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Cancer-associated fibroblasts in papillary thyroid carcinoma"],"prefix":"10.1007","volume":"23","author":[{"given":"Li","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qicheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuanghu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoyu","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiming","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaowei","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,30]]},"reference":[{"issue":"9","key":"998_CR1","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nrc.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri R. The biology and function of fibroblasts in cancer. Nat Rev Cancer. 2016;16(9):582\u201398.","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"998_CR2","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1016\/j.celrep.2015.11.052","volume":"13","author":"F Calvo","year":"2015","unstructured":"Calvo F, Ranftl R, Hooper S, et al. Cdc42EP3\/BORG2 and septin network enables mechano-transduction and the emergence of cancer-associated fibroblasts. Cell Rep. 2015;13(12):2699\u2013714.","journal-title":"Cell Rep"},{"issue":"1","key":"998_CR3","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.canlet.2016.02.003","volume":"374","author":"Y Ren","year":"2016","unstructured":"Ren Y, Zhou X, Liu X, et al. Reprogramming carcinoma associated fibroblasts by AC1MMYR2 impedes tumor metastasis and improves chemotherapy efficacy. Cancer Lett. 2016;374(1):96\u2013106.","journal-title":"Cancer Lett"},{"key":"998_CR4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1475-2867-14-41","volume":"14","author":"G Kharaishvili","year":"2014","unstructured":"Kharaishvili G, Simkova D, Bouchalova K, Gachechiladze M, Narsia N, Bouchal J. The role of cancer-associated fibroblasts, solid stress and other microenvironmental factors in tumor progression and therapy resistance. Cancer Cell Int. 2014;14:41.","journal-title":"Cancer Cell Int"},{"issue":"5","key":"998_CR5","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41575-019-0115-0","volume":"16","author":"H Kobayashi","year":"2019","unstructured":"Kobayashi H, Enomoto A, Woods SL, Burt AD, Takahashi M, Worthley DL. Cancer-associated fibroblasts in gastrointestinal cancer. Nat Rev Gastroenterol Hepatol. 2019;16(5):282\u201395.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"11","key":"998_CR6","doi-asserted-by":"crossref","first-page":"6629","DOI":"10.21037\/tcr-20-2365","volume":"9","author":"J Gu","year":"2020","unstructured":"Gu J, Wang C, Xu X, et al. Immunohistochemical detection of cancer-associated fibroblasts in gastrointestinal cancer as a potential prognostic biomarker of survival: meta-analysis. Transl Cancer Res. 2020;9(11):6629\u201338.","journal-title":"Transl Cancer Res"},{"issue":"6","key":"998_CR7","doi-asserted-by":"crossref","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394\u2013424.","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"998_CR8","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1007\/s00405-018-5061-x","volume":"275","author":"JG Cho","year":"2018","unstructured":"Cho JG, Byeon HK, Oh KH, et al. Clinicopathological significance of cancer-associated fibroblasts in papillary thyroid carcinoma: a predictive marker of cervical lymph node metastasis. Eur Arch Otorhinolaryngol. 2018;275(9):2355\u201361.","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"998_CR9","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.2147\/OTT.S294725","volume":"14","author":"S Wen","year":"2021","unstructured":"Wen S, Qu N, Ma B, et al. Cancer-associated fibroblasts positively correlate with dedifferentiation and aggressiveness of thyroid cancer. Onco Targets Ther. 2021;14:1205\u201317.","journal-title":"Onco Targets Ther"},{"issue":"6","key":"998_CR10","doi-asserted-by":"crossref","first-page":"8197","DOI":"10.1007\/s13277-015-4684-4","volume":"37","author":"WY Sun","year":"2016","unstructured":"Sun WY, Jung WH, Koo JS. Expression of cancer-associated fibroblast-related proteins in thyroid papillary carcinoma. Tumour Biol. 2016;37(6):8197\u2013207.","journal-title":"Tumour Biol"},{"issue":"1","key":"998_CR11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC, et al. 2015 American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1\u2013133.","journal-title":"Thyroid"},{"key":"998_CR12","doi-asserted-by":"crossref","unstructured":"Perrier ND, Brierley JD, Tuttle RM (2018) Differentiated and anaplastic thyroid carcinoma: major changes in the American joint committee on cancer eighth edition cancer staging manual. Ca-a Cancer J Clin, 68(1):56\u201363.","DOI":"10.3322\/caac.21439"},{"issue":"1","key":"998_CR13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.lfs.2014.09.025","volume":"118","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Meng Z, Zhang M, et al. Immunohistochemical evaluation of midkine and nuclear factor-kappa B as diagnostic biomarkers for papillary thyroid cancer and synchronous metastasis. Life Sci. 2014;118(1):39\u201345.","journal-title":"Life Sci"},{"key":"998_CR14","volume":"9","author":"J Zhang","year":"2021","unstructured":"Zhang J, Qi J, Wei H, et al. TGFbeta1 in cancer-associated fibroblasts is associated with progression and radiosensitivity in small-cell lung cancer. Front Cell Dev Biol. 2021;9: 667645.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"998_CR15","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/s41392-021-00641-0","volume":"6","author":"F Wu","year":"2021","unstructured":"Wu F, Yang J, Liu J, et al. Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer. Signal Transduct Target Ther. 2021;6(1):218.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"998_CR16","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s40364-021-00305-9","volume":"9","author":"Z Wang","year":"2021","unstructured":"Wang Z, Liu J, Huang H, et al. Metastasis-associated fibroblasts: an emerging target for metastatic cancer. Biomark Res. 2021;9(1):47.","journal-title":"Biomark Res"},{"issue":"3","key":"998_CR17","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s12079-021-00624-4","volume":"15","author":"A Toti","year":"2021","unstructured":"Toti A, Santi A, Pardella E, et al. Activated fibroblasts enhance cancer cell migration by microvesicles-mediated transfer of Galectin-1. J Cell Commun Signal. 2021;15(3):405\u201319.","journal-title":"J Cell Commun Signal"},{"issue":"1","key":"998_CR18","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/imr.12982","volume":"302","author":"M Desbois","year":"2021","unstructured":"Desbois M, Wang Y. Cancer-associated fibroblasts: Key players in shaping the tumor immune microenvironment. Immunol Rev. 2021;302(1):241\u201358.","journal-title":"Immunol Rev"},{"issue":"2","key":"998_CR19","doi-asserted-by":"crossref","first-page":"964","DOI":"10.3390\/ijms23020964","volume":"23","author":"M Vokurka","year":"2022","unstructured":"Vokurka M, Lacina L, Brabek J, Kolar M, Ng YZ, Smetana K Jr. Cancer-associated fibroblasts influence the biological properties of malignant tumours via paracrine secretion and exosome production. Int J Mol Sci. 2022;23(2):964.","journal-title":"Int J Mol Sci"},{"key":"998_CR20","doi-asserted-by":"crossref","unstructured":"McAndrews KM, Chen Y, Darpolor JK et al: Identification of functional heterogeneity of carcinoma-associated fibroblasts with distinct il-6 mediated therapy resistance in pancreatic cancer. Cancer Discov 2022.","DOI":"10.1158\/2159-8290.CD-20-1484"},{"issue":"6","key":"998_CR21","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1158\/1078-0432.CCR-06-1746","volume":"13","author":"LR Henry","year":"2007","unstructured":"Henry LR, Lee HO, Lee JS, et al. Clinical implications of fibroblast activation protein in patients with colon cancer. Clin Cancer Res. 2007;13(6):1736\u201341.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"998_CR22","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1007\/s00262-021-02863-1","volume":"70","author":"L Zadka","year":"2021","unstructured":"Zadka L, Chabowski M, Grybowski D, Piotrowska A, Dziegiel P. Interplay of stromal tumor-infiltrating lymphocytes, normal colonic mucosa, cancer-associated fibroblasts, clinicopathological data and the immunoregulatory molecules of patients diagnosed with colorectal cancer. Cancer Immunol Immunother. 2021;70(9):2681\u2013700.","journal-title":"Cancer Immunol Immunother"},{"issue":"44","key":"998_CR23","doi-asserted-by":"crossref","first-page":"76116","DOI":"10.18632\/oncotarget.18814","volume":"8","author":"L Wang","year":"2017","unstructured":"Wang L, Cao L, Wang H, et al. Cancer-associated fibroblasts enhance metastatic potential of lung cancer cells through IL-6\/STAT3 signaling pathway. Oncotarget. 2017;8(44):76116\u201328.","journal-title":"Oncotarget"},{"issue":"1","key":"998_CR24","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s13277-013-1053-z","volume":"35","author":"J Zhang","year":"2014","unstructured":"Zhang J, Wang Y, Li D, Jing S. Notch and TGF-beta\/Smad3 pathways are involved in the interaction between cancer cells and cancer-associated fibroblasts in papillary thyroid carcinoma. Tumour Biol. 2014;35(1):379\u201385.","journal-title":"Tumour Biol"},{"key":"998_CR25","volume":"9","author":"X Geng","year":"2021","unstructured":"Geng X, Chen H, Zhao L, et al. Cancer-associated fibroblast (CAF) heterogeneity and targeting therapy of CAFs in pancreatic cancer. Front Cell Dev Biol. 2021;9: 655152.","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"998_CR26","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109009","volume":"35","author":"N Bota-Rabassedas","year":"2021","unstructured":"Bota-Rabassedas N, Banerjee P, Niu Y, et al. Contextual cues from cancer cells govern cancer-associated fibroblast heterogeneity. Cell Rep. 2021;35(3): 109009.","journal-title":"Cell Rep"},{"issue":"3","key":"998_CR27","doi-asserted-by":"crossref","first-page":"3519","DOI":"10.1096\/fj.201903188R","volume":"34","author":"VS LeBleu","year":"2020","unstructured":"LeBleu VS, Neilson EG. Origin and functional heterogeneity of fibroblasts. Faseb J. 2020;34(3):3519\u201336.","journal-title":"Faseb J"},{"key":"998_CR28","volume":"12","author":"T Yan","year":"2021","unstructured":"Yan T, Qiu W, Weng H, Fan Y, Zhou G, Yang Z. Single-cell transcriptomic analysis of ecosystems in papillary thyroid carcinoma progression. Front Endocrinol (Lausanne). 2021;12: 729565.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"998_CR29","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/ng.3818","volume":"49","author":"H Li","year":"2017","unstructured":"Li H, Courtois ET, Sengupta D, et al. Reference component analysis of single-cell transcriptomes elucidates cellular heterogeneity in human colorectal tumors. Nat Genet. 2017;49(5):708\u201318.","journal-title":"Nat Genet"},{"issue":"21","key":"998_CR30","doi-asserted-by":"crossref","first-page":"5914","DOI":"10.1158\/1078-0432.CCR-13-0694","volume":"19","author":"M Herrera","year":"2013","unstructured":"Herrera M, Islam AB, Herrera A, et al. Functional heterogeneity of cancer-associated fibroblasts from human colon tumors shows specific prognostic gene expression signature. Clin Cancer Res. 2013;19(21):5914\u201326.","journal-title":"Clin Cancer Res"},{"issue":"8","key":"998_CR31","volume":"10","author":"TK Kilvaer","year":"2015","unstructured":"Kilvaer TK, Khanehkenari MR, Hellevik T, et al. Cancer associated fibroblasts in stage I-IIIA NSCLC: prognostic impact and their correlations with tumor molecular markers. PLoS ONE. 2015;10(8): e0134965.","journal-title":"PLoS ONE"},{"issue":"10","key":"998_CR32","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.3390\/ph14101023","volume":"14","author":"S Imlimthan","year":"2021","unstructured":"Imlimthan S, Moon ES, Rathke H, et al. New frontiers in cancer imaging and therapy based on radiolabeled fibroblast activation protein inhibitors: a rational review and current progress. Pharmaceuticals (Basel). 2021;14(10):1023.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"21","key":"998_CR33","doi-asserted-by":"crossref","first-page":"5567","DOI":"10.3390\/cancers13215567","volume":"13","author":"S Ulisse","year":"2021","unstructured":"Ulisse S, Baldini E, Lauro A, et al. Papillary thyroid cancer prognosis: an evolving field. Cancers (Basel). 2021;13(21):5567.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"998_CR34","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.surg.2019.03.031","volume":"167","author":"V Harries","year":"2020","unstructured":"Harries V, Wang LY, McGill M, et al. Should multifocality be an indication for completion thyroidectomy in papillary thyroid carcinoma? Surgery. 2020;167(1):10\u20137.","journal-title":"Surgery"},{"issue":"10","key":"998_CR35","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1001\/jamaoto.2021.1976","volume":"147","author":"H Kim","year":"2021","unstructured":"Kim H, Kwon H, Moon BI. Association of multifocality with prognosis of papillary thyroid carcinoma: a systematic review and meta-analysis. JAMA Otolaryngol Head Neck Surg. 2021;147(10):847\u201354.","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"10","key":"998_CR36","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1001\/archsurg.135.10.1194","volume":"135","author":"A Ohshima","year":"2000","unstructured":"Ohshima A, Yamashita H, Noguchi S, et al. Indications for bilateral modified radical neck dissection in patients with papillary carcinoma of the thyroid. Arch Surg. 2000;135(10):1194\u20138 (discussion 1199).","journal-title":"Arch Surg"},{"issue":"11","key":"998_CR37","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.3390\/cancers14112757","volume":"14","author":"IA Lee","year":"2022","unstructured":"Lee IA, Moon G, Kang S, et al. Predictive factors indicative of hemithyroidectomy and close follow-up versus bilateral total thyroidectomy for aggressive variants of papillary thyroid cancer. Cancers (Basel). 2022;14(11):2757.","journal-title":"Cancers (Basel)"},{"issue":"5","key":"998_CR38","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.21037\/gs-20-430","volume":"9","author":"FA Rashid","year":"2020","unstructured":"Rashid FA, Munkhdelger J, Fukuoka J, Bychkov A. Prevalence of BRAF(V600E) mutation in Asian series of papillary thyroid carcinoma-a contemporary systematic review. Gland Surg. 2020;9(5):1878\u2013900.","journal-title":"Gland Surg"},{"key":"998_CR39","first-page":"6562149","volume":"2022","author":"Z Ye","year":"2022","unstructured":"Ye Z, Xia X, Xu P, et al. The prognostic implication of the BRAF V600E mutation in papillary thyroid cancer in a Chinese population. Int J Endocrinol. 2022;2022:6562149.","journal-title":"Int J Endocrinol"},{"issue":"7","key":"998_CR40","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1002\/iub.2056","volume":"71","author":"Z Meng","year":"2019","unstructured":"Meng Z, Matsuse M, Saenko V, et al. TERT promoter mutation in primary papillary thyroid carcinoma lesions predicts absent or lower (131) I uptake in metastases. IUBMB Life. 2019;71(7):1030\u201340.","journal-title":"IUBMB Life"},{"issue":"10","key":"998_CR41","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1089\/thy.2012.0453","volume":"23","author":"XM Yu","year":"2013","unstructured":"Yu XM, Schneider DF, Leverson G, Chen H, Sippel RS. Follicular variant of papillary thyroid carcinoma is a unique clinical entity: a population-based study of 10,740 cases. Thyroid. 2013;23(10):1263\u20138.","journal-title":"Thyroid"},{"issue":"8","key":"998_CR42","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/modpathol.3880153","volume":"13","author":"ZW Baloch","year":"2000","unstructured":"Baloch ZW, LiVolsi VA. Encapsulated follicular variant of papillary thyroid carcinoma with bone metastases. Mod Pathol. 2000;13(8):861\u20135.","journal-title":"Mod Pathol"},{"issue":"3","key":"998_CR43","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s12020-020-02229-0","volume":"68","author":"C Giani","year":"2020","unstructured":"Giani C, Torregrossa L, Piaggi P, et al. Outcome of classical (CVPTC) and follicular (FVPTC) variants of papillary thyroid cancer: 15 years of follow-up. Endocrine. 2020;68(3):607\u201316.","journal-title":"Endocrine"},{"issue":"3","key":"998_CR44","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1620\/tjem.252.209","volume":"252","author":"F Maletta","year":"2020","unstructured":"Maletta F, Falco EC, Gambella A, Metovic J, Papotti M. Noninvasive follicular thyroid neoplasm with papillary-like nuclear features: from echography to genetic profile. Tohoku J Exp Med. 2020;252(3):209\u201318.","journal-title":"Tohoku J Exp Med"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-00998-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-023-00998-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-00998-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T13:11:49Z","timestamp":1696079509000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-023-00998-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,30]]},"references-count":44,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,10]]}},"alternative-id":["998"],"URL":"https:\/\/doi.org\/10.1007\/s10238-023-00998-2","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,30]]},"assertion":[{"value":"28 July 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests. The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of Tianjin Medical University General Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Statement"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}